Atik Cameras launches ChemiMOS

What Is It? A new cooled CMOS camera, optimized for long exposure imaging

Atik Cameras, a specialist designer and manufacturer of advanced scientific cameras, has launched ChemiMOS, the first in a series of high-resolution complementary metal-oxide semiconductor (CMOS) cameras.

Atik Cameras is thrilled to launch ChemiMOS 9.0 today. This 9-megapixel camera, with a set point cooling of -20°C, has been optimized for long exposures. Hours of exposure time has previously only been available with CCD technology but is now possible with CMOS technology thanks to the ChemiMOS zero-amp glow and low-noise design.

The square format, ‘K’ grade sensor is guaranteed for continuous use, while the 3000 × 3000 resolution and 3.76 µm pixel size are perfect for multiple scientific applications including chemiluminescence, western blotting and gel documentation. Benefits include very low-read noise of less than 2 e and deep pixel full well of greater than 50,000 e, allowing for unprecedented dynamic range.

Cooling is optimized to minimize the dark current to around 0.005 e/p/s, without the need for extreme temperatures, allowing for superior end-user design. This latest generation of CMOS technology will be available for the foreseeable future, ensuring long-term, supply chain stability.

Additionally, Atik Cameras provides a collaborative customization service. ChemiMOS can be supplied with a wide range of bespoke options, including an in/out trigger or an adapted case to suit specific requirements. Other sensors that can be available in this series include 26 MP, 60 MP, 102 MP, and 150 MP.

A comprehensive software development kit is available, complete with expert integration assistance with our in-house team. Calibration routines such as dark frame subtraction and off-camera image processing are included, meaning flexibility and transparency when operating the camera. There is no downtime for recalibration as the sensor characteristics change over time.

Atik Cameras CEO Dr. Panos Kapetanopoulos commented, ‘Atik is delighted to be at the forefront of this industry-leading technology. We are able to offer new and existing customers a CMOS alternative that delivers superior performance amongst long stare cameras, formerly only seen in CCD cameras’

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

LumiGuide, powered by Fiber Optic RealShape (FORS) technology, enables doctors to navigate through blood vessels using light, instead of X- ray. “[It’s] one of the most exciting changes that we’ve seen with imaging certainly throughout my career,” said Andres Schanzer, Vascular Surgeon, at UMass Memorial Medical Center, Worcester, MA, USA.
Carestream Health notes twenty-seven of the patents were awarded by the U.S. Patent and Trademark Office; an additional 43 patents were received in European and Asian countries.
According to an Insightec study, patients experienced significant reductions in upper limb tremor, tremor-related disability, and quality of life. The most common intraprocedural adverse events included dizziness, headache, nausea, and vomiting, which all resolved. Post-procedural adverse events included paraesthesia and gait disturbance, which were often transient or resolved within 12 months.
Chris Landon, Business Leader Image Guided Therapy Devices at Philips: “IVUS is a technology that has demonstrated an ability to both support safer procedures for patients and procedural staff alike including reductions in radiation exposure. As the global leader in IVUS solutions, we are grateful for the rigorous multidisciplinary approach to developing expert consensus on the value of IVUS and we look forward to working with all stakeholders to standardize the use of IVUS and reduce the barriers preventing utilization.”
"We are delighted to see our 3D solution CE-marked and available on the European market," says Ulrik Harrysson, CEO at SyntheticMR AB. "SyMRI 3D represents the next generation of quantitative MRI, offering unprecedented resolution and accuracy in brain imaging, revolutionizing the landscape of medical diagnostics."

By using this website you agree to accept Medical Device News Magazine Privacy Policy